Arctic University of Norway Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2017
NCT03181360
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

UiT The Arctic University of Norway | UiT The artic University of Norway / Norwegian Welfare Service Troms

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cerebral Infarction (Phase 3)

Ischemia (Phase 3)

Neonatal Sepsis (Phase 3)

Stroke (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 4